Drug therapy for acute myeloid leukemiaMartin S. Tallman, Jacob M. Rowe, D. Gary Gilliland|Blood|2005Cited by 670
The OTT-MAL fusion oncogene activates RBPJ-mediated transcription and induces acute megakaryoblastic leukemia in a knockin mouse modelThomas Mercher, D. Gary Gilliland|Journal of Clinical Investigation|2009Cited by 110
Human pituitary adenomas show no loss of heterozygosity at the retinoblastoma gene locus.Jiguang Zhu, Peter McL. Black, Alan H. Beggs et al.|The Journal of Clinical Endocrinology & Metabolism|1994Cited by 84
Variable sensitivity of FLT3 activation loop mutations to the small molecule tyrosine kinase inhibitor MLN518Jennifer Clark, D. Gary Gilliland|Blood|2004Cited by 80
Stable expression of small interfering RNA sensitizes TEL-PDGFβR to inhibition with imatinib or rapamycinJing Chen, D. Gary Gilliland|Journal of Clinical Investigation|2004Cited by 58